Cargando…
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
Autores principales: | van der Pluijm, Rob W, Peto, Thomas J, Hamaluba, Mainga, Callery, James J, Tripura, Rupam, White, Nicholas J, Dondorp, Arjen M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613573/ https://www.ncbi.nlm.nih.gov/pubmed/35643100 http://dx.doi.org/10.1016/S1473-3099(22)00283-3 |
Ejemplares similares
-
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
por: Peto, Thomas J, et al.
Publicado: (2022) -
Village malaria workers for the community-based management of vivax malaria
por: Adhikari, Bipin, et al.
Publicado: (2022) -
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
por: van der Pluijm, Rob W, et al.
Publicado: (2020) -
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
por: Tindana, Paulina, et al.
Publicado: (2021) -
Letter to the editor RE: Reuling et al., 2018 ‘liver injury in uncomplicated malaria is an overlooked phenomenon: An observational study’
por: Dondorp, Arjen M., et al.
Publicado: (2021)